Health & Beauty

"Three traditional Chinese medicine products received the drug registration certificate issued by Uzbekistan, which is one of the few successful cases of Chinese patent medicine products registered under Chinese drug standards." Lanzhou Foci Pharmaceutical Co., Ltd. (hereinafter referred to as "Foci Pharmaceutical") Deputy General Manager Wang Yingchun said in an exclusive interview with a reporter from China News Agency on the 29th that there are still seven famous Chinese medicine prescriptions that are expected to be approved for medicine certificates this year, marking that Gansu Chinese medicine companies have entered the "fast lane" of international development.

The "China Time-honored Brand" Foci Pharmaceuticals has a history of nearly a hundred years. It pioneered the technology of concentrated pills of traditional Chinese medicine, opened the precedent for the industrialization of traditional Chinese medicine production, and became an advocate of the idea of "Western Chinese medicine". In 1931, Foci concentrated pills crossed the oceans and exported to Southeast Asia. Foci became the first company to promote Chinese patent medicine to the international market.

According to reports, the three classic Chinese medicine prescriptions registered in Uzbekistan this time are Huoxiang Zhengqi Pills, Fangfeng Tongsheng Pills and Xiao Chaihu Tang Pills, which are also classic Chinese medicine prescription products, and have obtained Uzbekistan's medicine certificate for the first time.

The products and techniques handed down from generation to generation, combined with the planting area and comprehensive output of Chinese medicinal materials in Gansu, rank first in China, with abundant Chinese medicinal materials resources. In recent years, Foci Pharmaceuticals has taken advantage of the development opportunities of the “Belt and Road” to usher in a good opportunity to “go global”.

In 2020, Foci Pharmaceuticals donated Huoxiang Zhengqi Pills, Angong Niuhuang Pills and other anti-epidemic drugs to Uzbekistan. The "Mysterious Oriental Herbal Medicine" is effective in fighting the new crown pneumonia epidemic and is recognized by the Uzbek people and government.

"Not only that, the application for Uzbekistan's registered drug certificate has been shortened from 2 years to half a year in the previous registration review period." Wang Yingchun believes that simplifying the certification procedures and shortening the processing time actually reflect overseas recognition of Chinese medicine products.

In recent years, Foci Pharma has sold proprietary Chinese medicines in Russia, Ukraine and other countries, and went to Brazil, Denmark, Kazakhstan and other countries to explore overseas markets for Chinese medicine. At present, its products are exported to 29 countries and regions, there are 35 foreign registered trademarks, and more than 200 export products. It has been continuously rated as "China's Top Ten Exporters of Chinese Patent Medicines". The number of products exported, countries of export, and coverage are all ranked in the industry. Forefront.

Wang Yingchun said that Foci Pharmaceuticals will accelerate the internationalization of Chinese medicine, and cooperate in the establishment of a China-Uzbekistan Chinese Medicine Center in Uzbekistan; assist the Brazilian authorities in completing the Chinese medicine legislation, and is committed to Longyao going abroad, telling the story of Chinese Chinese medicine to the world, and helping to spread it. Chinese medicine culture.